News
Eisai (ESALF) and Eli Lilly (LLY) post new long-term data for thier Alzheimer's drugs Leqembi and Kisunla, respectively. Read more here.
7h
Stockhead on MSNDoubling up: How ASX biotechs are multiplying their impactASX companies such as LTR Pharma are finding smarter ways to stretch the value of existing assets and launch into broader ...
Though nerves abound for funders and founders in the industry, money continues to flow into startups, sometimes in ...
Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for ...
Haroon Akhtar emphasised that the establishment of a pharmaceutical joint venture between Pakistan and Russia marks a ...
22h
Sportschosun on MSNNovo Nordisk Market Vaps KRW 97 Trillion in a Day...GLP1 family obesity drug growth slowdown signal?Novo Nordisk shares plunged more than 20% on the 29th (local time) in New York and Denmark on the 29th (local time) due to the announcement of a slowdown in sales growth of the obesity drug "Wegovy".
We recently published 10 Stocks That Jim Cramer Talked About. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim ...
See all the late mail, official team news and updates for Round 5 of the 2025 NRL Telstra Women's Premiership.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results